Publications

cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of china.	this study assessed the cost-effectiveness of a new, rapid human papillomavirus (hpv)-dna screening test for cervical cancer prevention in the high-risk region of shanxi, china. using micro-costing methods, we estimated the resources needed to implement preventive strategies using cervical cytology or hpv-dna testing, including the hybrid capture 2 (hc2) test (qiagen corp., gaithersburg, md) and the rapid hpv-dna carehpv test (qiagen). data were used in a previously published model and empirical ...	2010	20049838
a new hpv-dna test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural china.	a new test (carehpv; qiagen, gaithersburg, md, usa) has been developed to detect 14 high-risk types of carcinogenic human papillomavirus (hpv) in about 2.5 h, to screen women in developing regions for cervical intraepithelial neoplasia (cin). we did a cross-sectional study to assess the clinical accuracy of carehpv as a rapid screening test in two county hospitals in rural china.	2008	18805733